Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less-Reference-Cited by-同舟云学术

Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less

Published:2021-04-02 Issue:3 Volume:4 Page:
ISSN:2398-9238
Container-title:Endocrinology, Diabetes & Metabolism
language:en
Short-container-title:Endocrinol Diab Metab

Author:

Flory James H¹^ORCID,Li Jing²,Dawwas Ghadeer K.³,Leonard Charles E.³^ORCID

Affiliation:

1. Department of Subspecialty Medicine Endocrinology Service Memorial Sloan Kettering Cancer Center New York NY USA

2. Department of Population Health Sciences Weill Cornell Medicine New York NY USA

3. Department of Biostatistics, Epidemiology, and Informatics Center for Pharmacoepidemiology Research and Training Perelman School of MedicineUniversity of Pennsylvania Philadelphia PA USA

Funder

National Cancer Institute - Singapore

Agency for Healthcare Research and Quality

Patient-Centered Outcomes Research Institute

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/edm2.245

Reference22 articles.

1. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020

2. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

3. Twelve‐year trends in pharmacologic treatment of type 2 diabetes among patients with heart failure in the United States

4. Adoption of New Glucose-Lowering Medications in the U.S.—The Case of SGLT2 Inhibitors: Nationwide Cohort Study

5. Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication adherence to sodium‐glucose cotransporter‐2 inhibitors versus glucagon‐like peptide‐1 receptor agonists: A meta‐analysis;Diabetes, Obesity and Metabolism;2024-07-23

2. Adoption of new medicines in primary care: A comparison between the uptake of new oral anticoagulants and diabetes medicines;British Journal of Clinical Pharmacology;2023-12-04

3. Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes;The American Journal of Managed Care;2023-12-01

4. Genetics and epigenetics of diabetes and its complications in India;Human Genetics;2023-11-24